VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q63363451 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000339.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q63363451‏
024 ‎‡a 0000-0002-2185-5476‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q63363451‏
100 0 ‎‡a Joseph D Turner‏ ‎‡9 es‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a জোসেফ ডি টার্নার‏ ‎‡9 bn‏
400 0 ‎‡a Joseph D Turner‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Joseph D Turner‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis‏
670 ‎‡a Author's A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection.‏
670 ‎‡a Author's Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis.‏
670 ‎‡a Author's AWZ1066S, a highly specific anti- drug candidate for a short-course treatment of filariasis‏
670 ‎‡a Author's Blood flukes exploit Peyer's Patch lymphoid tissue to facilitate transmission from the mammalian host‏
670 ‎‡a Author's Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis‏
670 ‎‡a Author's CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection‏
670 ‎‡a Author's Circulating CD14brightCD16+ 'intermediate' monocytes exhibit enhanced parasite pattern recognition in human helminth infection‏
670 ‎‡a Author's Comparison of immune responses to Loa loa stage-specific antigen extracts in Loa loa-exposed BALB/c mice upon clearance of infection‏
670 ‎‡a Author's Cytokine response profiles predict species-specific infection patterns in human GI nematodes‏
670 ‎‡a Author's Dataset on in vitro maintenance of Mansonella perstans microfilariae and drug testing‏
670 ‎‡a Author's Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity‏
670 ‎‡a Author's Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections‏
670 ‎‡a Author's Enhanced pro-inflammatory cytokine responses following Toll-like-receptor ligation in Schistosoma haematobium-infected schoolchildren from rural Gabon‏
670 ‎‡a Author's Eosinophil-Mediated Immune Control of Adult Filarial Nematode Infection Can Proceed in the Absence of IL-4 Receptor Signaling‏
670 ‎‡a Author's Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa.‏
670 ‎‡a Author's Fluorescent imaging of antigen released by a skin-invading helminth reveals differential uptake and activation profiles by antigen presenting cells‏
670 ‎‡a Author's Gastrointestinal nematode infection is associated with variation in innate immune responsiveness‏
670 ‎‡a Author's Generation of Loa loa infective larvae by experimental infection of the vector, Chrysops silacea‏
670 ‎‡a Author's Human filarial Wolbachia lipopeptide directly activates human neutrophils in vitro‏
670 ‎‡a Author's <i>Wolbachia</i> depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathment‏
670 ‎‡a Author's Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol‏
670 ‎‡a Author's In vitro maintenance of Mansonella perstans microfilariae and its relevance for drug screening‏
670 ‎‡a Author's In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis‏
670 ‎‡a Author's In vivo kinetics of Wolbachia depletion by ABBV-4083 in L. sigmodontis adult worms and microfilariae‏
670 ‎‡a Author's Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides‏
670 ‎‡a Author's Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness‏
670 ‎‡a Author's Interleukin-4 activated macrophages mediate immunity to filarial helminth infection by sustaining CCR3-dependent eosinophilia.‏
670 ‎‡a Author's Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.‏
670 ‎‡a Author's Mouse models of Loa loa‏
670 ‎‡a Author's Multiple helminth infection of the skin causes lymphocyte hypo-responsiveness mediated by Th2 conditioning of dermal myeloid cells.‏
670 ‎‡a Author's Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?‏
670 ‎‡a Author's Onchocerca ochengi male worms implanted in SCID mice and Gerbil: Relationship between microfilaridermia status of cows, nodular worm viability and fertility and worm survival in the rodents‏
670 ‎‡a Author's Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis‏
670 ‎‡a Author's Schistosome infection is associated with enhanced whole-blood IL-10 secretion in response to cercarial excretory/secretory products‏
670 ‎‡a Author's Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.‏
670 ‎‡a Author's Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models‏
670 ‎‡a Author's Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird models‏
670 ‎‡a Author's T helper cell type 2 responsiveness predicts future susceptibility to gastrointestinal nematodes in humans.‏
670 ‎‡a Author's Th2 Cytokines Are Associated with Reduced Worm Burdens in a Human Intestinal Helminth Infection‏
670 ‎‡a Author's The Mannose Receptor‏
670 ‎‡a Author's The Mannose Receptor (CD206) is an important pattern recognition receptor (PRR) in the detection of the infective stage of the helminth Schistosoma mansoni and modulates IFNγ production.‏
670 ‎‡a Author's The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.‏
670 ‎‡a Author's Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models.‏
670 ‎‡a Author's Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon‏
670 ‎‡a Author's Wolbachia endosymbionts induce neutrophil extracellular trap formation in human onchocerciasis.‏
670 ‎‡a Author's Wolbachia-induced neutrophil activation in a mouse model of ocular onchocerciasis‏
670 ‎‡a Author's Wolbachia-induced neutrophil activation in a mouse model of ocular onchocerciasis (river blindness).‏
670 ‎‡a Author's Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis.‏
909 ‎‡a (orcid) 0000000221855476‏ ‎‡9 1‏
919 ‎‡a intensityofintestinalinfectionwithmultiplewormspeciesisrelatedtoregulatorycytokineoutputandimmunehyporesponsiveness‏ ‎‡A Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness‏ ‎‡9 1‏
919 ‎‡a murinemacrofilaricidepreclinicalscreeningmodelforonchocerciasisandlymphaticfilariasis‏ ‎‡A A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis‏ ‎‡9 1‏
919 ‎‡a randomizeddoubleblindclinicaltrialofa3weekcourseofdoxycyclineplusalbendazoleandivermectinforthetreatmentofwuchereriabancroftiinfection‏ ‎‡A A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection.‏ ‎‡9 1‏
919 ‎‡a albendazoleandantibioticssynergizetodelivershortcourseantiwolbachiacurativetreatmentsinpreclinicalmodelsoffilariasis‏ ‎‡A Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis.‏ ‎‡9 1‏
919 ‎‡a minocyclineasarepurposedantiwolbachiamacrofilaricidesuperioritycomparedwithdoxycyclineregimensinamurineinfectionmodelofhumanlymphaticfilariasis‏ ‎‡A Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.‏ ‎‡9 1‏
919 ‎‡a mousemodelsofloaloa‏ ‎‡A Mouse models of Loa loa‏ ‎‡9 1‏
919 ‎‡a multiplehelminthinfectionoftheskincauseslymphocytehyporesponsivenessmediatedbyth2conditioningofdermalmyeloidcells‏ ‎‡A Multiple helminth infection of the skin causes lymphocyte hypo-responsiveness mediated by Th2 conditioning of dermal myeloid cells.‏ ‎‡9 1‏
919 ‎‡a novelantiwolbachiadrugsanewapproachinthetreatmentandpreventionofveterinaryfilariasis‏ ‎‡A Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?‏ ‎‡9 1‏
919 ‎‡a onchocercaochengimalewormsimplantedinscidmiceandgerbilrelationshipbetweenmicrofilaridermiastatusofcowsnodularwormviabilityandfertilityandwormsurvivalintherodents‏ ‎‡A Onchocerca ochengi male worms implanted in SCID mice and Gerbil: Relationship between microfilaridermia status of cows, nodular worm viability and fertility and worm survival in the rodents‏ ‎‡9 1‏
919 ‎‡a preclinicaldevelopmentofanoralantiwolbachiamacrolidedrugforthetreatmentoflymphaticfilariasisandonchocerciasis‏ ‎‡A Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis‏ ‎‡9 1‏
919 ‎‡a schistosomeinfectionisassociatedwithenhancedwholebloodil10secretioninresponsetocercarialexcretorysecretoryproducts‏ ‎‡A Schistosome infection is associated with enhanced whole-blood IL-10 secretion in response to cercarial excretory/secretory products‏ ‎‡9 1‏
919 ‎‡a shortcoursehighdoserifampicinachieveswolbachiadepletionpredictiveofcurativeoutcomesinpreclinicalmodelsoflymphaticfilariasisandonchocerciasis‏ ‎‡A Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.‏ ‎‡9 1‏
919 ‎‡a shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels‏ ‎‡A Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models‏ ‎‡9 1‏
919 ‎‡a shortcoursequinazolinedrugtreatmentsareeffectiveinthelitomosoidessigmodontisandbrugiapahangijirdmodels‏ ‎‡A Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird models‏ ‎‡9 1‏
919 ‎‡a thelpercelltype2responsivenesspredictsfuturesusceptibilitytogastrointestinalnematodesinhumans‏ ‎‡A T helper cell type 2 responsiveness predicts future susceptibility to gastrointestinal nematodes in humans.‏ ‎‡9 1‏
919 ‎‡a th2cytokinesareassociatedwithreducedwormburdensinahumanintestinalhelminthinfection‏ ‎‡A Th2 Cytokines Are Associated with Reduced Worm Burdens in a Human Intestinal Helminth Infection‏ ‎‡9 1‏
919 ‎‡a awz1066sahighlyspecificantidrugcandidateforashortcoursetreatmentoffilariasis‏ ‎‡A AWZ1066S, a highly specific anti- drug candidate for a short-course treatment of filariasis‏ ‎‡9 1‏
919 ‎‡a mannosereceptor‏ ‎‡A The Mannose Receptor‏ ‎‡9 1‏
919 ‎‡a mannosereceptorcd206isanimportantpatternrecognitionreceptorprrinthedetectionoftheinfectivestageofthehelminthschistosomamansoniandmodulatesifnγproduction‏ ‎‡A The Mannose Receptor (CD206) is an important pattern recognition receptor (PRR) in the detection of the infective stage of the helminth Schistosoma mansoni and modulates IFNγ production.‏ ‎‡9 1‏
919 ‎‡a bloodflukesexploitpeyerspatchlymphoidtissuetofacilitatetransmissionfromthemammalianhost‏ ‎‡A Blood flukes exploit Peyer's Patch lymphoid tissue to facilitate transmission from the mammalian host‏ ‎‡9 1‏
919 ‎‡a tlr26ligandpam2csk4isath2polarizingadjuvantinleishmaniamajorandbrugiamalayimurinevaccinemodels‏ ‎‡A The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.‏ ‎‡9 1‏
919 ‎‡a validationofultrasoundbioimagingtopredictwormburdenandtreatmentefficacyinpreclinicalfilariasisdrugscreeningmodels‏ ‎‡A Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models.‏ ‎‡9 1‏
919 ‎‡a boronpleuromutilinsasantiwolbachiaagentswithpotentialfortreatmentofonchocerciasisandlymphaticfilariasis‏ ‎‡A Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis‏ ‎‡9 1‏
919 ‎‡a whyonchocerciasistransmissionpersistsafter15annualivermectinmassdrugadministrationsinsouthwestcameroon‏ ‎‡A Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon‏ ‎‡9 1‏
919 ‎‡a wolbachiaendosymbiontsinduceneutrophilextracellulartrapformationinhumanonchocerciasis‏ ‎‡A Wolbachia endosymbionts induce neutrophil extracellular trap formation in human onchocerciasis.‏ ‎‡9 1‏
919 ‎‡a cd4+cd25+regulatorycellscontributetotheregulationofcolonicth2granulomatouspathologycausedbyschistosomeinfection‏ ‎‡A CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection‏ ‎‡9 1‏
919 ‎‡a wolbachiainducedneutrophilactivationinamousemodelofocularonchocerciasis‏ ‎‡A Wolbachia-induced neutrophil activation in a mouse model of ocular onchocerciasis‏ ‎‡9 1‏
919 ‎‡a wolbachiainducedneutrophilactivationinamousemodelofocularonchocerciasisriverblindness‏ ‎‡A Wolbachia-induced neutrophil activation in a mouse model of ocular onchocerciasis (river blindness).‏ ‎‡9 1‏
919 ‎‡a circulatingcd14brightcd16+intermediatemonocytesexhibitenhancedparasitepatternrecognitioninhumanhelminthinfection‏ ‎‡A Circulating CD14brightCD16+ 'intermediate' monocytes exhibit enhanced parasite pattern recognition in human helminth infection‏ ‎‡9 1‏
919 ‎‡a wolbachialipoproteinstimulatesinnateandadaptiveimmunitythroughtolllikereceptors2and6toinducediseasemanifestationsoffilariasis‏ ‎‡A Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis.‏ ‎‡9 1‏
919 ‎‡a comparisonofimmuneresponsestoloaloastagespecificantigenextractsinloaloaexposedbalb100miceuponclearanceofinfection‏ ‎‡A Comparison of immune responses to Loa loa stage-specific antigen extracts in Loa loa-exposed BALB/c mice upon clearance of infection‏ ‎‡9 1‏
919 ‎‡a cytokineresponseprofilespredictspeciesspecificinfectionpatternsinhumanginematodes‏ ‎‡A Cytokine response profiles predict species-specific infection patterns in human GI nematodes‏ ‎‡9 1‏
919 ‎‡a interleukin4activatedmacrophagesmediateimmunitytofilarialhelminthinfectionbysustainingccr3dependenteosinophilia‏ ‎‡A Interleukin-4 activated macrophages mediate immunity to filarial helminth infection by sustaining CCR3-dependent eosinophilia.‏ ‎‡9 1‏
919 ‎‡a datasetoninvitromaintenanceofmansonellaperstansmicrofilariaeanddrugtesting‏ ‎‡A Dataset on in vitro maintenance of Mansonella perstans microfilariae and drug testing‏ ‎‡9 1‏
919 ‎‡a discoveryofabbv4083anovelanalogoftylosinathathaspotentantiwolbachiaandantifilarialactivity‏ ‎‡A Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity‏ ‎‡9 1‏
919 ‎‡a discoveryofshortcourseantiwolbachialquinazolinesforeliminationoffilarialworminfections‏ ‎‡A Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections‏ ‎‡9 1‏
919 ‎‡a enhancedproinflammatorycytokineresponsesfollowingtolllikereceptorligationinschistosomahaematobiuminfectedschoolchildrenfromruralgabon‏ ‎‡A Enhanced pro-inflammatory cytokine responses following Toll-like-receptor ligation in Schistosoma haematobium-infected schoolchildren from rural Gabon‏ ‎‡9 1‏
919 ‎‡a eosinophilmediatedimmunecontrolofadultfilarialnematodeinfectioncanproceedintheabsenceofil4receptorsignaling‏ ‎‡A Eosinophil-Mediated Immune Control of Adult Filarial Nematode Infection Can Proceed in the Absence of IL-4 Receptor Signaling‏ ‎‡9 1‏
919 ‎‡a evaluationofinvitroculturesystemsforthemaintenanceofmicrofilariaeandinfectivelarvaeofloaloa‏ ‎‡A Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa.‏ ‎‡9 1‏
919 ‎‡a fluorescentimagingofantigenreleasedbyaskininvadinghelminthrevealsdifferentialuptakeandactivationprofilesbyantigenpresentingcells‏ ‎‡A Fluorescent imaging of antigen released by a skin-invading helminth reveals differential uptake and activation profiles by antigen presenting cells‏ ‎‡9 1‏
919 ‎‡a gastrointestinalnematodeinfectionisassociatedwithvariationininnateimmuneresponsiveness‏ ‎‡A Gastrointestinal nematode infection is associated with variation in innate immune responsiveness‏ ‎‡9 1‏
919 ‎‡a generationofloaloainfectivelarvaebyexperimentalinfectionofthevectorchrysopssilacea‏ ‎‡A Generation of Loa loa infective larvae by experimental infection of the vector, Chrysops silacea‏ ‎‡9 1‏
919 ‎‡a humanfilarialwolbachialipopeptidedirectlyactivateshumanneutrophilsinvitro‏ ‎‡A Human filarial Wolbachia lipopeptide directly activates human neutrophils in vitro‏ ‎‡9 1‏
919 ‎‡a wolbachia1depletionblockstransmissionoflymphaticfilariasisbypreventingchitinasedependentparasiteexsheathment‏ ‎‡A <i>Wolbachia</i> depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathment‏ ‎‡9 1‏
919 ‎‡a implementationoftestandtreatwithdoxycyclineandtemephosgroundlarvicidingasalternativestrategiesforacceleratingonchocerciasiseliminationinanareaofloiasiscoendemicitythecountdownconsortiummultidisciplinarystudyprotocol‏ ‎‡A Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol‏ ‎‡9 1‏
919 ‎‡a invitromaintenanceofmansonellaperstansmicrofilariaeanditsrelevancefordrugscreening‏ ‎‡A In vitro maintenance of Mansonella perstans microfilariae and its relevance for drug screening‏ ‎‡9 1‏
919 ‎‡a invivoefficacyoftheboronpleuromutilinan11251againstwolbachiaoftherodentfilarialnematodelitomosoidessigmodontis‏ ‎‡A In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis‏ ‎‡9 1‏
919 ‎‡a invivokineticsofwolbachiadepletionbyabbv4083in50sigmodontisadultwormsandmicrofilariae‏ ‎‡A In vivo kinetics of Wolbachia depletion by ABBV-4083 in L. sigmodontis adult worms and microfilariae‏ ‎‡9 1‏
919 ‎‡a industrialscalehighthroughputscreeningdeliversmultiplefastactingmacrofilaricides‏ ‎‡A Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 RERO|A003915489‏
996 ‎‡2 NTA|443383871‏
996 ‎‡2 J9U|987012501703805171‏
996 ‎‡2 BLBNB|000371657‏
996 ‎‡2 DE633|pe30007150‏
996 ‎‡2 RERO|A027031138‏
996 ‎‡2 J9U|987011296163705171‏
996 ‎‡2 BNC|981058511933206706‏
996 ‎‡2 NSK|000123958‏
996 ‎‡2 ISNI|0000000123070202‏
996 ‎‡2 BNE|XX865570‏
996 ‎‡2 PLWABN|9810653788305606‏
996 ‎‡2 NKC|xx0148297‏
996 ‎‡2 LC|n 81146968‏
996 ‎‡2 NLA|000035791674‏
996 ‎‡2 CAOONL|ncf10105898‏
996 ‎‡2 NUKAT|n 2015057238‏
996 ‎‡2 BLBNB|000445775‏
996 ‎‡2 ISNI|0000000027822611‏
996 ‎‡2 NLA|000035558816‏
996 ‎‡2 DNB|1169163874‏
996 ‎‡2 NTA|159563216‏
996 ‎‡2 NSK|000312488‏
996 ‎‡2 CAOONL|ncf10098861‏
996 ‎‡2 ISNI|0000000081386507‏
996 ‎‡2 KRNLK|KAC199627992‏
996 ‎‡2 DNB|135779855‏
996 ‎‡2 SUDOC|254091520‏
996 ‎‡2 ISNI|0000000067308916‏
996 ‎‡2 DNB|1267045914‏
996 ‎‡2 LC|n 82026527‏
996 ‎‡2 ISNI|0000000051431506‏
996 ‎‡2 ISNI|0000000379668566‏
996 ‎‡2 BAV|495_17459‏
996 ‎‡2 BAV|495_17458‏
996 ‎‡2 DNB|134543416‏
996 ‎‡2 CAOONL|ncf11918034‏
996 ‎‡2 B2Q|0000087425‏
996 ‎‡2 BIBSYS|11044847‏
996 ‎‡2 LC|no2006132850‏
996 ‎‡2 CAOONL|ncf10301339‏
996 ‎‡2 JPG|500026846‏
996 ‎‡2 BNC|981058515000406706‏
996 ‎‡2 LC|no2002114163‏
996 ‎‡2 ISNI|0000000387023645‏
996 ‎‡2 BIBSYS|90140722‏
996 ‎‡2 RERO|A022682418‏
996 ‎‡2 W2Z|11044847‏
996 ‎‡2 LC|n 85029480‏
996 ‎‡2 LC|no2021099349‏
996 ‎‡2 NSK|000770596‏
996 ‎‡2 ISNI|0000000378631972‏
996 ‎‡2 J9U|987007269175705171‏
996 ‎‡2 N6I|vtls000077244‏
996 ‎‡2 LC|n 83027934‏
996 ‎‡2 ISNI|0000000107812958‏
996 ‎‡2 BIBSYS|1602157051772‏
996 ‎‡2 LC|n 2020024379‏
996 ‎‡2 LC|no2022029592‏
996 ‎‡2 CAOONL|ncf10488586‏
996 ‎‡2 NYNYRILM|516‏
996 ‎‡2 DNB|125729375‏
996 ‎‡2 ISNI|0000000073930920‏
996 ‎‡2 BIBSYS|1707990460486‏
996 ‎‡2 ISNI|0000000417111161‏
996 ‎‡2 ISNI|0000000115525182‏
996 ‎‡2 NUKAT|n 97088094‏
996 ‎‡2 DBC|87097992374653‏
996 ‎‡2 BIBSYS|56047‏
996 ‎‡2 PLWABN|9810578840105606‏
996 ‎‡2 J9U|987007369267405171‏
996 ‎‡2 LC|nr2006012793‏
996 ‎‡2 ISNI|0000000121454990‏
996 ‎‡2 ISNI|0000000367185014‏
996 ‎‡2 LC|no2017052753‏
996 ‎‡2 BLBNB|000530656‏
996 ‎‡2 ISNI|0000000077238691‏
996 ‎‡2 BIBSYS|1663831673100‏
996 ‎‡2 SUDOC|07807617X‏
996 ‎‡2 ISNI|000000008308983X‏
996 ‎‡2 JPG|500197394‏
996 ‎‡2 LC|n 93070693‏
996 ‎‡2 ISNI|0000000408445055‏
996 ‎‡2 SUDOC|085906980‏
996 ‎‡2 NTA|130280895‏
996 ‎‡2 BNF|14501710‏
996 ‎‡2 J9U|987007371483205171‏
996 ‎‡2 LC|n 86846625‏
996 ‎‡2 DBC|87097992374572‏
996 ‎‡2 RERO|A022719583‏
996 ‎‡2 RERO|A022792817‏
996 ‎‡2 NII|DA02050076‏
996 ‎‡2 BNF|14040298‏
996 ‎‡2 LC|no2011018733‏
996 ‎‡2 ISNI|0000000109110810‏
996 ‎‡2 LC|n 88190868‏
996 ‎‡2 LC|n 2013045507‏
996 ‎‡2 BIBSYS|90404793‏
996 ‎‡2 NTA|068543573‏
996 ‎‡2 LC|nr 92035119‏
996 ‎‡2 JPG|500043763‏
996 ‎‡2 ISNI|0000000071529623‏
996 ‎‡2 CAOONL|ncf11484298‏
996 ‎‡2 LC|n 2008040865‏
996 ‎‡2 LC|n 79060712‏
996 ‎‡2 LC|no 91026772‏
996 ‎‡2 LC|n 2012017535‏
996 ‎‡2 NII|DA0843422X‏
996 ‎‡2 RERO|A017376974‏
996 ‎‡2 SUDOC|027332446‏
996 ‎‡2 CAOONL|ncf11346851‏
996 ‎‡2 RERO|A011464468‏
996 ‎‡2 LC|no2011157483‏
996 ‎‡2 NTA|071463410‏
996 ‎‡2 LC|n 91042263‏
996 ‎‡2 ICCU|UBOV511603‏
996 ‎‡2 LC|n 2023036972‏
996 ‎‡2 J9U|987007436023005171‏
996 ‎‡2 ISNI|0000000054163260‏
996 ‎‡2 NUKAT|n 2014140262‏
996 ‎‡2 LC|no2007152194‏
996 ‎‡2 LC|n 84043003‏
996 ‎‡2 BIBSYS|90086560‏
996 ‎‡2 LC|n 2023066555‏
996 ‎‡2 LC|n 50016156‏
996 ‎‡2 ERRR|12190342‏
996 ‎‡2 PTBNP|204704‏
996 ‎‡2 N6I|vtls000063994‏
996 ‎‡2 BLBNB|000370937‏
996 ‎‡2 J9U|987007373336705171‏
996 ‎‡2 DNB|134543408‏
996 ‎‡2 NDL|00459271‏
996 ‎‡2 ISNI|0000000034589985‏
996 ‎‡2 DNB|135780284‏
996 ‎‡2 ISNI|000000003215497X‏
996 ‎‡2 SUDOC|077442016‏
996 ‎‡2 LC|n 86819930‏
996 ‎‡2 LC|no2018048665‏
996 ‎‡2 BNF|17932211‏
996 ‎‡2 N6I|vtls000022850‏
996 ‎‡2 BNC|981058518396406706‏
996 ‎‡2 BIBSYS|90107028‏
996 ‎‡2 UIY|000083025‏
996 ‎‡2 ISNI|0000000065107248‏
996 ‎‡2 ISNI|0000000067465532‏
996 ‎‡2 ISNI|0000000114757272‏
996 ‎‡2 LC|n 87145652‏
996 ‎‡2 BIBSYS|90501337‏
996 ‎‡2 LC|no 98026890‏
996 ‎‡2 NTA|24110548X‏
996 ‎‡2 ISNI|0000000498176142‏
996 ‎‡2 BIBSYS|3046957‏
996 ‎‡2 J9U|987007340558705171‏
996 ‎‡2 ISNI|000000010928268X‏
996 ‎‡2 LC|nr 94009232‏
996 ‎‡2 RERO|A005909776‏
996 ‎‡2 LC|no2012160659‏
996 ‎‡2 LC|n 94086927‏
996 ‎‡2 ISNI|0000000046864083‏
996 ‎‡2 ISNI|0000000026459232‏
996 ‎‡2 LC|n 98017699‏
996 ‎‡2 BNF|12418130‏
996 ‎‡2 DNB|134745418‏
996 ‎‡2 ISNI|0000000497426496‏
996 ‎‡2 PLWABN|9810654632405606‏
996 ‎‡2 NSK|000043731‏
996 ‎‡2 DNB|1070491047‏
996 ‎‡2 J9U|987007419170005171‏
996 ‎‡2 SUDOC|136158323‏
996 ‎‡2 NUKAT|n 2006116984‏
996 ‎‡2 CAOONL|ncf10013619‏
996 ‎‡2 BIBSYS|90867150‏
996 ‎‡2 NII|DA06250576‏
996 ‎‡2 SUDOC|157332462‏
996 ‎‡2 CAOONL|ncf10243927‏
996 ‎‡2 DNB|1322933049‏
996 ‎‡2 N6I|vtls000364182‏
996 ‎‡2 J9U|987007378424005171‏
996 ‎‡2 BIBSYS|90115506‏
996 ‎‡2 LC|n 2007008949‏
996 ‎‡2 LC|nr 98003847‏
996 ‎‡2 ISNI|0000000383664090‏
996 ‎‡2 LC|n 82090670‏
996 ‎‡2 NYNYRILM|140828‏
996 ‎‡2 J9U|987007320058705171‏
996 ‎‡2 LIH|LNB:V-103222;=_y__h_‏
996 ‎‡2 ISNI|0000000066405554‏
996 ‎‡2 RERO|A003915464‏
996 ‎‡2 J9U|987007384286205171‏
996 ‎‡2 NKC|xx0131346‏
996 ‎‡2 BNF|12013059‏
996 ‎‡2 LC|n 50080187‏
996 ‎‡2 RERO|A020054333‏
996 ‎‡2 LC|n 82149790‏
996 ‎‡2 LC|no2016082130‏
996 ‎‡2 DNB|1174025263‏
996 ‎‡2 JPG|500095485‏
996 ‎‡2 LC|n 89653092‏
996 ‎‡2 ISNI|0000000049887459‏
996 ‎‡2 NUKAT|n 2014052606‏
996 ‎‡2 NTA|266964109‏
996 ‎‡2 LC|n 97109594‏
996 ‎‡2 ISNI|0000000052193917‏
996 ‎‡2 SKMASNL|vtls012813905‏
996 ‎‡2 ISNI|0000000082128462‏
996 ‎‡2 LC|n 2014016048‏
996 ‎‡2 BAV|495_154471‏
996 ‎‡2 SUDOC|077863437‏
996 ‎‡2 J9U|987007444197605171‏
996 ‎‡2 NUKAT|n 94301423‏
996 ‎‡2 PLWABN|9810686135405606‏
996 ‎‡2 DBC|87097919117413‏
996 ‎‡2 NLA|000035751158‏
996 ‎‡2 RERO|A000164461‏
996 ‎‡2 BIBSYS|97037170‏
996 ‎‡2 DNB|11862475X‏
996 ‎‡2 CAOONL|ncf10000464‏
996 ‎‡2 BIBSYS|90407454‏
996 ‎‡2 ISNI|0000000430374011‏
996 ‎‡2 LC|nb 91080269‏
996 ‎‡2 NKC|uk20211101581‏
996 ‎‡2 NDL|00459267‏
996 ‎‡2 LC|no2008049836‏
996 ‎‡2 LC|n 92085800‏
996 ‎‡2 ISNI|0000000110053083‏
996 ‎‡2 ISNI|000000005433906X‏
996 ‎‡2 NTA|074259237‏
996 ‎‡2 NKC|ntk20211122840‏
996 ‎‡2 LNB|LNC10-000157400‏
996 ‎‡2 J9U|987007414423305171‏
996 ‎‡2 ISNI|0000000032730906‏
996 ‎‡2 ISNI|0000000102100054‏
996 ‎‡2 LIH|LNB:KB_y_;=B_c_‏
996 ‎‡2 BIBSYS|1058811‏
996 ‎‡2 LC|n 2014024780‏
996 ‎‡2 RERO|A020301160‏
996 ‎‡2 NII|DA00374237‏
996 ‎‡2 DNB|1158154704‏
996 ‎‡2 RERO|A003915495‏
996 ‎‡2 BNF|14036215‏
996 ‎‡2 CAOONL|ncf10287663‏
996 ‎‡2 CAOONL|ncf10276181‏
996 ‎‡2 LC|no2023135939‏
996 ‎‡2 LC|no2008028561‏
996 ‎‡2 RERO|A011641218‏
996 ‎‡2 LC|no2008169996‏
996 ‎‡2 DBC|87097992374580‏
996 ‎‡2 W2Z|90086560‏
996 ‎‡2 LIH|LNB:CR03;=_r_5‏
996 ‎‡2 DNB|136020372‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏